Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Study of Pembrolizumab in Patients With Early-Stage NK/T-cell Lymphoma, Nasal Type

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03728972
Recruitment Status : Recruiting
First Posted : November 2, 2018
Last Update Posted : May 13, 2021
Sponsor:
Information provided by (Responsible Party):
Memorial Sloan Kettering Cancer Center

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : November 2022
Estimated Study Completion Date : November 2022